Nasdaq:US$13.87 (+0.13) | HKEX:HK$22.10 (+0.30) | AIM:£2.11 (+0.04)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF